 |
 |

Analysis of Tumor-Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma
Andreas C. Haeffner, MD;
Karoline Zepter, MD;
Craig A. Elmets, MD;
Gary S. Wood, MD
Arch Dermatol. 1997;133(5):585-590.
Abstract
Objective To characterize tumor-infiltrating lymphocytes (TILs) within lesions of cutaneous squamous cell carcinoma (SCC) and related disorders.
Design Case series with 1- and 2-color immunohistologic, molecular biological analysis of T-cell clonality and in vitro cytotoxicity assays.
Setting Academic medical center.
Patients Twenty-one patients, including 6 with actinic keratoses, 4 with SCC in situ, and 11 with invasive SCC.
Results CD8+ TILs were present within lesions of cutaneous SCC and AK. These cells constituted a variable minority of the total T-cell infiltrate, and many expressed a phenotype consistent with major histocompatibility complex—restricted cytotoxic T lymphocytes: CD3+, TIA1+, CD16-, CD56-, CD57-. They also expressed HLA-DR, suggesting their activation in vivo. Virtually all T cells were T-cell receptor (TCR)-β+ -, indicating that they expressed the TCR- β protein heterodimer. Molecular biological analysis of TCR- gene rearrangements by the polymerase chain reaction and denaturing gradient gel electrophoresis technique indicated that the TILs were polyclonal. Functional studies suggested that TILs derived from SCC lesions were cytotoxic for autologous tumor cell targets.
Conclusion Tumor-infiltrating lymphocytes within cutaneous SCC lesions contain a subpopulation of polyclonal, major histocompatibility complex—restricted cytotoxic T lymphocytes expressing the TCR- β heterodimer.
Arch Dermatol. 1997;133:585-590
Author Affiliations
From the Departments of Dermatology (Drs Haeffner, Zepter, Elmets, and Wood) and Pathology (Dr Wood), and the Skin Diseases Research Center (Drs Haeffner, Zepter, Elmets, and Wood), Case Western Reserve University, and the Veterans Affairs Medical Center (Dr Wood), Cleveland, Ohio. Dr Haeffner is now affiliated with the Department of Dermatology, University of Zurich, Zurich, Switzerland. Dr Zepter is now with the Department of Dermatology, University of Aachen, Aachen, Germany.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Immunosuppressive Level and Other Risk Factors for Basal Cell Carcinoma and Squamous Cell Carcinoma in Heart Transplant Recipients
Fortina et al.
Arch Dermatol 2004;140:1079-1085.
ABSTRACT
| FULL TEXT
Acitretin for Hypertrophic Lichen Planus-Like Reaction in a Burn Scar
Kossard and Artemi
Arch Dermatol 2000;136:591-594.
FULL TEXT
Is Favorable Prognosis of Squamous Cell Carcinoma of the Skin Due to Efficient Immune Surveillance?
Smolle and Wolf
Arch Dermatol 1997;133:645-646.
ABSTRACT
|